Cited by 59Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchRNA Research and Splicing

U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer’s disease due to autosomal dominant genetic mutations and trisomy 21

Open access
Hales, Chadwick M, Seyfried, Nicholas T, Dammer, Eric B, Duong, Duc, Yi, Hong, Gearing, Marla, Troncoso, Juan C, Mufson, Elliott J +3 more·2014·Molecular Neurodegeneration

Abstract

BACKGROUND: We recently identified U1 small nuclear ribonucleoprotein (snRNP) tangle-like aggregates and RNA splicing abnormalities in sporadic Alzheimer's disease (AD). However little is known about snRNP biology in early onset AD due to autosomal dominant genetic mutations or trisomy 21 in Down syndrome. Therefore we investigated snRNP biochemical and pathologic features in these disorders. FINDINGS: We performed quantitative proteomics and immunohistochemistry in postmortem brain from genetic AD cases. Electron microscopy was used to characterize ultrastructural features of pathologic aggregates. U1-70k and other snRNPs were biochemically enriched in the insoluble fraction of human brain from subjects with presenilin 1 (PS1) mutations. Aggregates of U1 snRNP-immunoreactivity formed cytoplasmic tangle-like structures in cortex of AD subjects with PS1 and amyloid precursor protein (APP) mutations as well as trisomy 21. Ultrastructural analysis with electron microscopy in an APP mutation case demonstrated snRNP immunogold labeling of paired helical filaments (PHF). CONCLUSIONS: These studies identify U1 snRNP pathologic changes in brain of early onset genetic forms of AD. Since dominant genetic mutations and trisomy 21 result in dysfunctional amyloid processing, the findings suggest that aberrant β-amyloid processing may influence U1 snRNP aggregate formation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1750-1326-9-15

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hales, C. M., Seyfried, N. T., Dammer, E. B., Duong, D., Yi, H., Gearing, M., Troncoso, J. C., Mufson, E. J., Thambisetty, M., Levey, A. I., & Lah, J. J.
Affiliations
  • Emory University (US)
  • Johns Hopkins University (US)
  • Rush University (US)
  • National Institutes of Health (US)
Corresponding author
Lah, James J
Venue
Molecular Neurodegeneration
Published
2014-04-28
Volume
9
Issue
1
Pages
15-15
ISSN
1750-1326 (ISSN-L)
OpenAlex
W2143216632
Cited by
58
References
28
Citations by year
2026: 4 · 2025: 8 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 6 · 2020: 5 · 2019: 2 · 2018: 10 · 2017: 5 · 2016: 4 · 2015: 2 · 2014: 1
FWCI
2.67
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Molecular Neurodegeneration (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Alzheimer's Association (NIRG-12-242297)
  • American Brain Foundation
  • Emory University (AG025688, P30NS055077)
  • University of Washington
  • National Institutes of Health (AG05136, AG025688)
  • Alzheimer's Disease Research Center, Emory University (AG025688, AG05136)
  • National Institute on Aging (P50 AG05136, AG 05136, AG 025688, P01AG014449, P01 AG14449, R01AG043375, P50AG005136, P50AG025688)
  • National Institute of Neurological Disorders and Stroke (P30NS055077)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Keywords
U1 snRNA, small nuclear ribonucleoproteins, Alzheimer's disease, Down syndrome, presenilin 1 mutations, amyloid precursor protein mutations, RNA splicing, protein aggregation, paired helical filaments
MeSH terms
Adult, Aged, Aged, 80 and over, Alzheimer Disease, Down Syndrome, Female, Humans, Immunohistochemistry, Male, Middle Aged, Mutation, Amyloid beta-Protein Precursor, Ribonucleoprotein, U1 Small Nuclear, Microscopy, Electron, Transmission, Presenilin-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review